Clinical and dosimetric risk factors of acute esophagitis in patients treated with 3-dimensional conformal radiotherapy for non-small-cell lung cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 33, Issue 3, 2010, Pages 271-275

  Zhang, Zi Cheng ^a   Xu, Jin ^a   Li, Bao Sheng ^a   Zhou, Tao ^a   Lu, Jie ^a   Wang, Zhong Tang ^a   Li, Hong Sheng ^a   Sun, Hong Fu ^a   Zhu, Jian ^a   Yu, Jin Ming ^a  

^a SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

3 dimensional conformal radiotherapy; Concurrent chemotherapy; Dose volumetric parameter; Non small cell lung cancer; Radiation esophagitis

Indexed keywords

CISPLATIN; DOCETAXEL; ETOPOSIDE; GEMCITABINE; MITOMYCIN; NAVELBINE; VINDESINE;

ADULT; AGED; ARTICLE; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; DOSIMETRY; ESOPHAGITIS; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROGNOSIS; RETROSPECTIVE STUDY; WEIGHT REDUCTION;

ACUTE DISEASE; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHINA; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; ESOPHAGITIS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 77953329537     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181a879e0     Document Type: Article

References (22)

1. Cox JD, Pajak TF, Asbell S, et al. Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non- small-cell carcinoma of the lung: analysis of 1244 cases from three Radiation Therapy Oncology Group (RTOG) trials. Int J Radiat Oncol Biol Phys. 1993;27:493-498.
2. Koukourakis M, Hlouverakis G, Kosma L, et al. The impact of overall treatment time on the results of radiotherapy for non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys. 1996;34:315-322.
3. Chen M, Jiang GL, Fu XL, et al. The impact of overall treatment time on outcomes in radiation therapy for nonsmall cell lung cancer. Lung Cancer. 2000;28:11-19.
4. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341-1346.
5. Tyldesley S, Boyd C, Schulze K, et al. Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach. Int J Radiat Oncol Biol Phys. 2001;49:973-985.
6. Fournel P, Robinet G, Thomas P, et al; Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95-01 Study. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced nonsmallcell lung cancer. J Clin Oncol. 2005;23:5910-5917.
7. Socinski MA, Zhang C, Herndon JE II, et al. Combined modality trials of the Cancer and Leukemia Group B in stage III nonsmall-cell lung cancer: analysis of factors influencing survival and toxicity. Ann Oncol. 2004;15: 1033-1041.
8. Werner-Wasik M, Pequignot E, Leeper D, et al. Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy. Int J Radiat Oncol Biol Phys. 2000;48:689-696.
9. Singh AK, Lockett MA, Bradley JD, et al. Predictors of radiation-induced esophageal toxicity in patients with nonsmall-cell lung cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2003;55:337-341.
10. Bradley J, Deasy JO, Bentzen S, et al. Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma. Int J Radiat Oncol Biol Phys. 2004;58:1106-1113.
11. Belderbos J, Heemsbergen W, Hoogeman M, et al. Acute esophageal toxicity in nonsmall cell lung cancer patients after high dose conformal radiotherapy. Radiother Oncol. 2005;75:157-164.
12. Kim TH, Cho KH, Pyo HR, et al. Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2005;62:995-1002.
13. Qiao WB, Zhao YH, Zhao YB, et al. Clinical and dosimetric factors of radiation-induced esophageal injury: radiation-induced esophageal toxicity. World-J-Gastroenterol. 2005;11:2626-2629.
14. Sause W, Kolesar P, Taylor S, et al; Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Final results of phase III trial in regionally advanced unresectable nonsmall cell lung cancer. Chest. 2000;117:358-364.
15. Curran WJ, Scott CB, Langer CJ, et al. Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresectable stage III NSCLC: RTOG 9410 [abstract]. Proc Am Soc Clin Oncol. 2003;22:2499.
16. Ahn SJ, Kahn D, Zhou S, et al. Dosimetric and clinical predictors for radiation-induced esophageal injury. Int J Radiat Oncol Biol Phys. 2005;61: 335-347.
17. Wei X, Liu HH, Tucker SL, et al. Risk factors for acute esophagitis in nonsmall-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2006;66:100-107.
18. Takeda K, Nemoto K, Saito H, et al. Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2005;62:626-629.
19. Hirota S, Tsujino K, Endo M, et al. Dosimetric predictors of radiation esophagitis in patients treated for nonsmall-cell lung cancer with carboplatin/ paclitaxel/radiotherapy. Int J Radiat Oncol Biol Phys. 2001;51:291-295.
20. Patel AB, Edelman MJ, Kwok Y, et al. Predictors of acute esophagitis in patients with nonsmall-cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery. Int J Radiat Oncol Biol Phys. 2004;60:1106-1112.
21. Algara M, Rodríguez N, Viñals P, et al. Prevention of radiochemotherapyinduced esophagitis with glutamine: results of a pilot study. Int J Radiat Oncol Biol Phys. 2007;69:342-349.
22. Maguire PD, Sibley GS, Zhou SM, et al. Clinical and dosimetric predictors of radiation-induced esophageal toxicity. Int J Radiat Oncol Biol Phys. 1999; 45:97-103.